Liu, X.; Fang, C.; Yu, H.; Huang, L.; Feng, J.; Luo, S.; Song, L.; Wu, M.; Tan, Y.; Dong, J.;
et al. Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis. Pharmaceutics 2025, 17, 351.
https://doi.org/10.3390/pharmaceutics17030351
AMA Style
Liu X, Fang C, Yu H, Huang L, Feng J, Luo S, Song L, Wu M, Tan Y, Dong J,
et al. Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis. Pharmaceutics. 2025; 17(3):351.
https://doi.org/10.3390/pharmaceutics17030351
Chicago/Turabian Style
Liu, Xunzhi, Changlong Fang, Hongling Yu, Lu Huang, Jiaxing Feng, Shiqin Luo, Li Song, Mengying Wu, Yulu Tan, Jianxia Dong,
and et al. 2025. "Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis" Pharmaceutics 17, no. 3: 351.
https://doi.org/10.3390/pharmaceutics17030351
APA Style
Liu, X., Fang, C., Yu, H., Huang, L., Feng, J., Luo, S., Song, L., Wu, M., Tan, Y., Dong, J., Gong, T., & Xiao, P.
(2025). Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis. Pharmaceutics, 17(3), 351.
https://doi.org/10.3390/pharmaceutics17030351
